Lupin Ltd.
Clinical trials sponsored by Lupin Ltd., explained in plain language.
-
New registry study monitors heart and skin risks of muscle drug in toddlers
Disease control Recruiting nowThis study follows up to 10 children from birth to under 6 years old who have genetic muscle stiffness disorders (myotonic disorders) and are taking mexiletine. Researchers will track side effects like heart rhythm problems and severe skin reactions over time. The goal is to unde…
Sponsor: Lupin Ltd. • Aim: Disease control
Last updated May 26, 2026 06:10 UTC
-
New hope for muscle stiffness: once-daily pill tested in myotonic dystrophy
Symptom relief Recruiting nowThis study tests whether a once-daily pill called mexiletine can safely reduce muscle stiffness (myotonia) in people with myotonic dystrophy types 1 and 2. About 176 adults aged 16 and older will take the drug or a placebo for 26 weeks. The main goal is to see if handgrip relaxat…
Phase: PHASE3 • Sponsor: Lupin Ltd. • Aim: Symptom relief
Last updated May 26, 2026 05:49 UTC
-
New Slow-Release drug may ease muscle stiffness with fewer side effects
Symptom relief Recruiting nowThis study tests whether a slow-release form of mexiletine (PR) works as well as the standard immediate-release form (IR) for easing muscle stiffness in people with non-dystrophic myotonias. About 24 adults will take both versions in a random order to compare safety and side effe…
Phase: PHASE3 • Sponsor: Lupin Ltd. • Aim: Symptom relief
Last updated May 18, 2026 12:10 UTC